• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿因子:与膀胱移行细胞癌复发的相关性

Rheumatoid factor: correlation with recurrence in transitional cell carcinoma of the bladder.

作者信息

Gupta N P, Malaviya A N, Singh S M

出版信息

J Urol. 1979 Apr;121(4):417-8. doi: 10.1016/s0022-5347(17)56803-2.

DOI:10.1016/s0022-5347(17)56803-2
PMID:439209
Abstract

The serum rheumatoid factor was measured by the latex fixation test in different titrations in 100 cases of bladder tumors. The rheumatoid factor was found in transitional and squamous cell carcinoma of the bladder. The percentage of positive studies correlated well with the clinical staging of the tumors. The rheumatoid factor activity also correlated with the recurrence of transitional cell carcinoma. A high recurrence rate was found when the rheumatoid factor was present in contrast to a low recurrence rate when it was absent at the initial examination. The percentage of recurrences correlated with the titration of the rheumatoid factor. The mechanism of production of the rheumatoid factor and its correlation with tumor recurrence are discussed.

摘要

采用乳胶凝集试验对100例膀胱肿瘤患者进行不同滴度的血清类风湿因子检测。在膀胱移行细胞癌和鳞状细胞癌中发现了类风湿因子。阳性研究的百分比与肿瘤的临床分期密切相关。类风湿因子活性也与移行细胞癌的复发相关。与初次检查时类风湿因子阴性时的低复发率相比,类风湿因子阳性时复发率较高。复发百分比与类风湿因子滴度相关。文中讨论了类风湿因子的产生机制及其与肿瘤复发的关系。

相似文献

1
Rheumatoid factor: correlation with recurrence in transitional cell carcinoma of the bladder.类风湿因子:与膀胱移行细胞癌复发的相关性
J Urol. 1979 Apr;121(4):417-8. doi: 10.1016/s0022-5347(17)56803-2.
2
Clinical usefulness of rheumatoid factor in urinary bladder tumours--a preliminary report.类风湿因子在膀胱肿瘤中的临床应用——初步报告
Indian J Med Res. 1977 Apr;65(4):563-5.
3
Immunologic reduction of bladder cancer recurrence rate.膀胱癌复发率的免疫性降低
J Urol. 1974 Feb;111(2):173-6. doi: 10.1016/s0022-5347(17)59919-x.
4
Rheumatoid factor in bladder tumors.膀胱肿瘤中的类风湿因子。
J Urol. 1978 Sep;120(3):296-7. doi: 10.1016/s0022-5347(17)57142-6.
5
Expression of SSEA-1 (Lewis(x)) on transitional cell carcinoma of the bladder.SSEA-1(Lewis(x))在膀胱移行细胞癌中的表达。
Urol Int. 1997;58(2):69-74. doi: 10.1159/000282953.
6
CA-50 as tumour marker in transitional bladder carcinoma.CA-50作为移行性膀胱癌的肿瘤标志物。
Br J Urol. 1989 Jun;63(6):616-8. doi: 10.1111/j.1464-410x.1989.tb05256.x.
7
Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.肿瘤相关抗原作为382例原发性膀胱移行细胞癌患者复发的预后因素
Clin Cancer Res. 1995 Oct;1(10):1195-202.
8
ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
J Urol. 1984 Feb;131(2):252-7. doi: 10.1016/s0022-5347(17)50333-x.
9
Isoantigens A, B and H in urinary bladder carcinomas following radiotherapy.放射治疗后膀胱癌中的同种抗原A、B和H
Cancer. 1978 May;41(5):1739-45. doi: 10.1002/1097-0142(197805)41:5<1739::aid-cncr2820410514>3.0.co;2-7.
10
[Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].[非侵入性尿液检测在膀胱癌诊断及预后标志物中的应用。BTAstat和NMP 22检测与使用抗Lewis X和486p3/12单克隆抗体的免疫细胞学检测的比较]
Urologe A. 2003 Apr;42(4):523-30. doi: 10.1007/s00120-002-0247-6. Epub 2003 Jan 17.

引用本文的文献

1
Corneal Perforation in a Patient Treated with Atezolizumab-Bevacizumab Combination Therapy for Unresectable Hepatocellular Carcinoma.阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌患者的角膜穿孔。
Am J Case Rep. 2023 Sep 1;24:e940688. doi: 10.12659/AJCR.940688.
2
Rheumatoid Factor: A Novel Determiner in Cancer History.类风湿因子:癌症病史中的一种新型决定因素。
Cancers (Basel). 2021 Feb 3;13(4):591. doi: 10.3390/cancers13040591.
3
Antiperinuclear activity in lung carcinoma patients.肺癌患者的抗核活性。
Cancer Immunol Immunother. 1984;18(2):80-1. doi: 10.1007/BF00205738.